Recently, the heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, and genomic-based therapies that are increasing the success of personalized medicine.
You may also be interested in:
Translating CTCs to Clinical Use
Regulatory Compliance in Molecular Diagnostics
Isolation and Characterization of Cancer Stem Cells
Using Preclinical Models in Oncology
Best Practices in Personalized and Translational Medicine